Endothelial expression of the receptor for advanced glycation end products in experimental diabetes
Int. j. med. surg. sci. (Print); 9 (2), 2022
The receptor for advanced glycation end products (RAGE) is implicated in the pathogenesis of several chronic diseases including diabetes. The interaction between RAGE and advanced glycation end products (AGEs) promotes gene expression, enhances the release of proinflammatory molecules and causes the gene...
Diabetes Mellitus Experimental, Receptor para Productos Finales de Glicación Avanzada/efectos de los fármacos, Losartán/farmacología, Enalapril/farmacología, Ratas Sprague-Dawley, Endotelio, Aorta Abdominal, Inmunohistoquímica, Receptor para Productos Finales de Glicación Avanzada/metabolismo, Inhibidores de la Enzima Convertidora de Angiotensina/farmacología, Bloqueadores del Receptor Tipo 1 de Angiotensina II/farmacología, d0120840